EyePoint Pharmaceuticals creates and sells injectable treatments and sustained-release implants to treat chronic eye diseases and inflammation. The company also develops new therapies that use specialized drug delivery systems to manage vision-threatening conditions over several months. I have synthesized my analysis of its core fundamentals, live market action, and peer metrics to provide a comprehensive thesis. What specific areas can I detail for you?
